Chapter Phar 1
AUTHORITY AND DEFINITIONS
Ch. Phar 1 NoteNote: Chapter Phar 1 as it existed on January 31, 1983 was repealed and a new chapter Phar 1 was created effective February 1, 1983.
Phar 1.01 HistoryHistory: Cr. Register, January, 1983, No. 325, eff. 2-1-83; am. Register, August, 1991, No. 428, eff. 9-1-91; am., Register, December, 1998, No. 516, eff. 1-1-99; am., Register, March, 2000, No. 531, eff. 4-1-00; correction made under s. 13.93 (2m) (b) 7., Stats., Register January 2002 No. 553; CR 17-090: am. Register July 2018 No. 751, eff. 8-1-18; EmR2303: emerg. am., eff. 2-3-23; CR 23-072: am. Register August 2024 No. 824, eff. 9-1-24; correction made under s. 35.17, Stats., Register August 2024 No. 824. Phar 1.02 NoteNote: The board office is located at 4822 Madison Yards Way, Madison, WI 53705.
Phar 1.02(2)(2) “Community pharmacy” means practice in a licensed pharmacy providing pharmaceutical services primarily on an outpatient basis. Phar 1.02(2m)(2m) “Department” means the Wisconsin department of safety and professional services. Phar 1.02(3)(3) “DEA” means the drug enforcement administration. Phar 1.02(3m)(3m) “Direct supervision” means immediate, whether in person or real time video conferencing where all parties can communicate by simultaneous means of audio, video, or data communications, availability to continually coordinate, direct and inspect in real time the practice of another. Phar 1.02(4)(4) “Institutional pharmacy” means practice in a licensed pharmacy providing pharmaceutical services primarily on an inpatient basis. Phar 1.02(6)(6) “Managing pharmacist” means a pharmacist designated by the pharmacy owner to have responsibility for and direct control of pharmaceutical operations in a pharmacy. Phar 1.02(6m)(6m) “NABP” means the National Association of Boards of Pharmacy. Phar 1.02(7)(7) “NAPLEX” means the North American Pharmacy Licensing Examination. Phar 1.02(10)(10) “Pharmacy” means any place of practice licensed by the board under s. 450.06 or 450.065, Stats., unless otherwise provided for in s. 450.065, Stats. Phar 1.02(10m)(10m) “Pharmacy graduate” means a graduate of a school of pharmacy approved by the board, who has submitted an application for pharmacist licensure or a qualified applicant awaiting examination for licensure approved by the board. Phar 1.02(11)(11) “Pharmacy owner” means a person or entity to whom a pharmacy license is issued. Phar 1.02(11m)(11m) “Pharmacy technician” means a person registered by the board under s. 450.068, Stats. Phar 1.02(14)(14) “Professional service area” means the area of a pharmacy in which prescriptions are compounded or dispensed, hypodermic needles, syringes, poisons and schedule V controlled substances as listed in s. 961.22, Stats., and ch. CSB 2 are available, or where patients are consulted. Phar 1.02(15)(15) “Terminal illness” means an incurable condition caused by injury or illness that reasonable medical judgment finds would cause death. Phar 1.02 HistoryHistory: Cr. Register, January, 1983, No. 325, eff. 2-1-83; am. (intro.), renum. (2) to (9) to be (6) to (12) and (14) and am. (8), (10) and (12), cr. (2) to (5) and (13), Register, August, 1991, No. 428, eff. 9-1-91; cr. (4m) and (15), Register, September, 1994, No. 465, eff. 10-1-94; am. (7), (8), (11) and (14), Register, December, 1998, No. 516, eff. 1-1-99; am. (intro.), Register, March, 2000, No. 531, eff. 4-1-00; emerg. cr. (3c), (4c), (4e), and (14m), eff. 1-1-02; correction in (intro.) made under s. 13.93 (2m) (b) 7., Stats., Register January 2002 No. 553; CR 14-023: am. (7) Register August 2014 No. 704, eff. 9-1-14; CR 15-064: am. (10) Register September 2016 No. 729, eff. 10-1-16; CR 16-017: cr. (6m) Register September 2016 No. 729, eff. 10-1-16; correction in (10) made under s. 35.17, Stats., Register September 2016 No. 729; 2017 Wis. Act 18: am. (4m) Register June 2017 No. 738, eff. July 1, 2017; CR 17-090: am. (intro.) Register July 2018 No. 751, eff. 8-1-18; EmR2213: emerg. r. (9), cr. (14m), eff. 11-1-22; CR 23-054; cr. (3m), r. (9), cr. (10m), (14m) Register August 2024 No. 824, eff. 9-1-24; EmR2303: emerg. am. (intro.), cr. (11m), eff. 2-3-23; CR 23-072: am. (intro.), cr. (2m), (11m) Register August 2024 No. 824, eff. 9-1-24.
/exec_review/admin_code/phar/1
true
administrativecode
/exec_review/admin_code/phar/1/02/14m
Pharmacy Examining Board (Phar)
administrativecode/Phar 1.02(14m)
administrativecode/Phar 1.02(14m)
section
true